- Home
- MDWD vs NEOV Comparison
MDWD vs NEOV Comparison
Compare MDWD & NEOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDWD
- NEOV
- Stock Information
- Founded
- MDWD 2000
- NEOV 2018
- Country
- MDWD Israel
- NEOV United States
- Employees
- MDWD N/A
- NEOV N/A
- Industry
- MDWD Medicinal Chemicals and Botanical Products
- NEOV Industrial Machinery/Components
- Sector
- MDWD Health Care
- NEOV Miscellaneous
- Exchange
- MDWD Nasdaq
- NEOV Nasdaq
- Market Cap
- MDWD 184.8M
- NEOV 181.8M
- IPO Year
- MDWD 2014
- NEOV N/A
- Fundamental
- Price
- MDWD $20.15
- NEOV $3.31
- Analyst Decision
- MDWD Strong Buy
- NEOV Strong Buy
- Analyst Count
- MDWD 1
- NEOV 1
- Target Price
- MDWD $25.00
- NEOV $7.50
- AVG Volume (30 Days)
- MDWD 78.0K
- NEOV 314.7K
- Earning Date
- MDWD 03-20-2025
- NEOV 02-11-2025
- Dividend Yield
- MDWD N/A
- NEOV N/A
- EPS Growth
- MDWD N/A
- NEOV N/A
- EPS
- MDWD N/A
- NEOV N/A
- Revenue
- MDWD $19,720,000.00
- NEOV $2,471,178.00
- Revenue This Year
- MDWD $10.15
- NEOV $85.10
- Revenue Next Year
- MDWD $25.62
- NEOV $281.25
- P/E Ratio
- MDWD N/A
- NEOV N/A
- Revenue Growth
- MDWD N/A
- NEOV N/A
- 52 Week Low
- MDWD $11.04
- NEOV $0.63
- 52 Week High
- MDWD $24.00
- NEOV $6.11
- Technical
- Relative Strength Index (RSI)
- MDWD 57.75
- NEOV 37.47
- Support Level
- MDWD $18.73
- NEOV $3.27
- Resistance Level
- MDWD $19.73
- NEOV $3.85
- Average True Range (ATR)
- MDWD 0.78
- NEOV 0.33
- MACD
- MDWD 0.02
- NEOV -0.04
- Stochastic Oscillator
- MDWD 66.35
- NEOV 13.12
About MDWD MediWound Ltd.
MediWound Ltd is an integrated biopharmaceutical company focused on developing, manufacturing, and commercializing novel therapeutic products to address unmet medical needs in the fields of severe burns, chronic and other hard-to-heal wounds, connective tissue disorders, and other indications. Its first biopharmaceutical product, NexoBrid is an FDA-approved orphan biologic for eschar removal in severe burns that can replace surgical interventions and minimize associated costs and complications. Its other product candidates in different stages of the pipeline include EscharEx for debridement of chronic wounds, and MW005 for the treatment of non-melanoma skin cancer. The company derives a majority of its revenue from the United States and the rest from the EU and other international markets.
About NEOV NeoVolta Inc.
NeoVolta Inc is engaged in designing, manufacturing and sale of high end Energy Storage System which can store and use solar energy via batteries and an inverter at a residential site. Its market place includes solar industry, installers, new construction homebuilders, home remodelers and homeowners.